Nature Biotechnology devoted an editorial to the positive contribution CRISPR can make to the democratization of agricultural biotechnology. The hope is that, without the burden of overregulation, even public institutes and small biotech companies can bring useful products from the lab to the fields. Gene editing without the introduction of “trans” sequences from other species can be given the suffix “cis,” hence the title of the article, Cis-editing for all.
Continue reading
By now it seems official. The first CRISPR plant to debut in the US market will not be a commodity for industry or intensive livestock farming, as was the case with classic GMOs in the 1990s. This time genetic innovation enters on tiptoe, with a food product designed for discerning consumers. A new type of salad, as nutrient-rich as a wild misticanza but without the bitter notes that usually relegate brassicas to foods to be eaten cooked (see here).
Continue reading
I must say that I’m a bit envious and eager to taste this kind of Brassica juncea with the “mustard bomb” mechanism prevented by knocking-out multiple copies of the gene responsible for the bitter taste.
Continue reading
CRISPeR FRENZY 